BIND Therapeutics: Credit Suisse Healthcare Conference (BIND Therapeutics) - Nov 15, 2014 - Anticipated stage 1 data readout for P2 trial for bladder, cervical, cholangio and neuroendocrine cancers in H1 2016; Anticipated stage 2 data readout for P2 trial for bladder, cervical, cholangio and neuroendocrine cancers in H2 2016; Anticipated randomized trial initiation for 2nd line NSCLC in H1 2015; Anticipated randomized trial initiation for 1st line mCRPC in H1 2015
Anticipated P2 data • Anticipated trial initiation date • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer
|